By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adare Pharmaceuticals 

Princeton Pike Corporate Center
1200 Lenox Drive, Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 1-609-450-1312 Fax: 1-609-896-1404


Adare Pharmaceuticals transforms medicines, creating new possibilities for improved patient health. We have expertise in overcoming complex formulation challenges and adding valuable IP to new and existing products—resulting in medicines that deliver greater value to all stakeholders, while meeting the needs of patients. We have the ability to transform drug formulations using our proprietary technologies, developing novel Rx and OTC products. Adare is uniquely suited to unlock the potential of more medicines, helping patients to maximize the benefit of their treatments. We are committed to partnering with innovators in the pharmaceutical industry. Visit and experience a partnership that's truly transformative.

Key Statistics

Ownership: Private

Web Site: Adare Pharma
Employees: 1,000


Company News
Adare Pharma to Expand Its Manufacturing and Formulation R&D, Expects to Create 29 Jobs 8/1/2017 7:55:24 AM
Adare Pharma Appoints Dr. Peter Richardson As Vice President, Research & Development And Chief Medical Officer 11/7/2016 11:22:46 AM
Adare Pharma Partners With Cincinnati Children's Hospital Medical Center On Innovation Fund 11/17/2015 10:47:27 AM
Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer 8/27/2015 9:28:03 AM
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies (FRX), Company Renamed Adare Pharmaceuticals 4/2/2015 10:43:25 AM
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015 2:02:37 PM
Forest Laboratories, Inc. (FRX) Sets $1.8 Billion High Yield Bond Deal To Back Aptalis Pharmaceutical Technologies Buy 1/28/2014 7:48:18 AM
Forest Laboratories, Inc. (FRX) Scoops Up Aptalis Pharmaceutical Technologies For $2.9 Billion Cash 1/8/2014 7:29:53 AM
Bridgewater-Based Aptalis Pharmaceutical Technologies Files To Raise $500 Million In IPO 12/27/2013 6:38:49 AM
Novamedica Signs Distribution Agreement With Aptalis Pharmaceutical Technologies To Develop And Commercialize Gastrointestinal Pharmaceutical Products In Russia 12/5/2013 10:00:00 AM